Literature DB >> 26867454

Treatment of visceral leishmaniasis: options and choice.

Sujit K Bhattacharya1, Aditya Prasad Dash2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26867454     DOI： 10.1016/S1473-3099(15)00528-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.

Authors:  Himanshu Kaushal; Sujit Kumar Bhattacharya; Sandeep Verma; Poonam Salotra
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.

Authors:  Sarah de Athayde Couto Falcão; Tatiana M G Jaramillo; Luciana G Ferreira; Daniela M Bernardes; Jaime M Santana; Cecília B F Favali
Journal:  Front Immunol       Date:  2016-08-03       Impact factor: 7.561

3.  Development of monoclonal antibodies against axenic amastigotes of Leishmania infantum strain in Iran: implication for diagnosis of Kala-azar.

Authors:  Ezzat Nourizadeh; Seyed Jalal Zargar; Mohammad Hossein Alimohammadian; Soheila Ajdary; Mahdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2018-04       Impact factor: 2.699

4.  Donor acquired visceral leishmaniasis following liver transplantation.

Authors:  Amritpal Dhaliwal; Abhishek Chauhan; Dinesh Aggarwal; Pretin Davda; Miruna David; Rasoul Amel-Kashipaz; Rachel Brown; Martin Dedicoat; Fiona Clark; Tahir Shah; Ahmed Mohamed Elsharkawy; Ines Ushiro-Lumb; Peter Chiodini; Omar El-Sherif; Matthew Armstrong; James W Ferguson
Journal:  Frontline Gastroenterol       Date:  2021-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.